Total (n=3743) | PMR (n=920) | GCA (n=2823) | |
Demographics | |||
Age at baseline*, years | 74.1 (3.6) | 71.6 (3.1) | 74.9 (3.7) |
% Female | 67.8 (10.6) | 71.0 (10.7) | 66.7 (10.5) |
Glucocorticoids use | |||
Cumulative dose, g | 7.6 (4.2) | 5.6 (3.3) | 8.2 (4.5) |
Duration of GC use, years | 2.4 (1.5) | 2.1 (1.2) | 2.5 (1.6) |
Follow-up | |||
Duration, years | 5.9 (4.1) | 4.4 (3.3) | 6.4 (4.4) |
All data are presented as a weighted mean (SD) across studies.
*Age at diagnosis (n=11), age at study inclusion (n=3), age unspecified in study (n=11).